MedTrace Logo

Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus

NCT02744378 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2016-04-20

No results posted yet for this study

Summary

This clinical study is carried out to assess the efficacy of Tacrolimus and Clobetasol in symptomatic Oral Lichen Planus.

Conditions

  • Oral Lichen Planus

Interventions

DRUG

Tacrolimus 0.1%

This group was randomly allocated to receive topical Tacrolimus 0.1% for 3 consecutive weeks

DRUG

Clobetasol 0.05%

This group was randomly allocated to receive topical Clobetasol 0.05% for 3 consecutive weeks

Sponsors & Collaborators

  • University of Peradeniya

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-07-31
Completion
2015-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02744378 on ClinicalTrials.gov